← Open Payments lookup

KATHERINE SCHULTHEISS: Open Payments

NPI 1558038901 · MESQUITE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,575 in 119 payments from 15 companies in 2025. Trend: 2023 $1,170 · 2024 $1,649 · 2025 $2,575

Food & beverage: $2,575
CompanyPaymentsAmount
ABBVIE INC.47$873
Janssen Biotech, Inc.20$500
Gilead Sciences, Inc.9$203
Ardelyx, Inc.6$157
GENZYME CORPORATION5$153
Madrigal Pharmaceuticals7$149
Takeda Pharmaceuticals U.S.A., Inc.4$104
Celltrion USA Inc.4$92
Phathom Pharmaceuticals, Inc.4$89
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$69

Products named: RINVOQ, TREMFYA, IBSRELA, DUPIXENT, REZDIFFRA, CREON, MAVYRET, SKYRIZI.

Industry payments across TX — which companies pay providers there.